USD 0.16
(0.0%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 10.61 Million USD | 671.04% |
2022 | 1.37 Million USD | -55.07% |
2021 | 3.06 Million USD | 10.49% |
2020 | 2.77 Million USD | -75.43% |
2019 | 11.28 Million USD | 111.35% |
2018 | 5.34 Million USD | 20.54% |
2017 | 4.43 Million USD | 2.5% |
2016 | 4.32 Million USD | 372.84% |
2015 | 914.27 Thousand USD | 1165.47% |
2014 | 72.24 Thousand USD | 5.39% |
2013 | 68.55 Thousand USD | -0.28% |
2012 | 68.74 Thousand USD | 4.37% |
2011 | 65.86 Thousand USD | 0.91% |
2010 | 65.27 Thousand USD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q1 | 11.48 Million USD | 8.18% |
2023 Q1 | 2.11 Million USD | 53.61% |
2023 Q3 | 10.43 Million USD | 24.63% |
2023 Q2 | 8.37 Million USD | 295.79% |
2023 FY | 10.61 Million USD | 671.04% |
2023 Q4 | 10.61 Million USD | 1.76% |
2022 Q1 | 3.18 Million USD | 3.99% |
2022 FY | 1.37 Million USD | -55.07% |
2022 Q4 | 1.37 Million USD | -50.46% |
2022 Q3 | 2.77 Million USD | -8.59% |
2022 Q2 | 3.04 Million USD | -4.61% |
2021 Q3 | 3.03 Million USD | 8.08% |
2021 FY | 3.06 Million USD | 10.49% |
2021 Q1 | 2.75 Million USD | -0.8% |
2021 Q2 | 2.81 Million USD | 2.16% |
2021 Q4 | 3.06 Million USD | 0.89% |
2020 Q3 | 4.61 Million USD | -99.9% |
2020 Q1 | 4.48 Billion USD | -60.26% |
2020 Q2 | 4.48 Billion USD | -0.04% |
2020 FY | 2.77 Million USD | -75.43% |
2020 Q4 | 2.77 Million USD | -39.94% |
2019 Q4 | 11.28 Billion USD | 0.0% |
2019 FY | 11.28 Million USD | 111.35% |
2018 Q4 | 5.34 Million USD | 0.0% |
2018 FY | 5.34 Million USD | 20.54% |
2017 FY | 4.43 Million USD | 2.5% |
2016 FY | 4.32 Million USD | 372.84% |
2015 FY | 914.27 Thousand USD | 1165.47% |
2015 Q2 | 16 Thousand USD | -78.02% |
2015 Q4 | 914.27 Thousand USD | 299.55% |
2015 Q3 | 228.82 Thousand USD | 1330.17% |
2015 Q1 | 72.78 Thousand USD | 0.75% |
2014 Q2 | 70.16 Thousand USD | 1.1% |
2014 Q1 | 69.4 Thousand USD | 1.24% |
2014 FY | 72.24 Thousand USD | 5.39% |
2014 Q4 | 72.24 Thousand USD | 1.69% |
2014 Q3 | 71.04 Thousand USD | 1.26% |
2013 FY | 68.55 Thousand USD | -0.28% |
2013 Q4 | 68.55 Thousand USD | 0.0% |
2012 FY | 68.74 Thousand USD | 4.37% |
2011 FY | 65.86 Thousand USD | 0.91% |
2010 FY | 65.27 Thousand USD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Alternative Energy Partners, Inc. | 3.15 Million USD | -236.692% |
Allstar Health Brands, Inc. | 9.3 Million USD | -14.116% |
Beijing Tong Ren Tang Chinese Medicine Company Limited | 52.97 Million USD | 79.958% |
Café Serendipity Holdings, Inc. | 1.31 Million USD | -705.652% |
Decision Diagnostics Corp. | - USD | -Infinity% |
Health Advance Inc. | 543.26 Thousand USD | -1854.292% |
HealthWarehouse.com, Inc. | 7.21 Million USD | -47.158% |
LIGAND PHARMACEUTICAL INC | 86.3 Million USD | 87.698% |
MedGen, Inc. | 43.63 USD | -24333954.55% |
Omni Health, Inc. | 1.94 Million USD | -446.809% |
Oxford Investments Holdings Inc. | 1.01 Million USD | -943.794% |
ScripsAmerica, Inc. | 9.16 Million USD | -15.815% |